Skip to the guide
Sermorelinfield notes

Sermorelin care · field notes

A real history.
A different product today.

Sermorelin tells a small gland just below the brain to release growth hormone, a chemical message; it does not put that hormone into your body.

Growth hormone is a message made by the body; children with too little of it may not grow normally.

For an adult, ask what benefit is expected beyond changing the amount of hormone in the blood.

Explore the field notes

Wasn’t sermorelin once approved?

Why this matters

First ask what the old drug was approved to treat. Then ask whether a pharmacy may make your medicine, and what research supports treating your problem.

What the name means

Sermorelin is a peptide made in a lab: tiny chemical parts joined in a short chain, like beads; proteins contain those same parts.

It copies a natural brain message that tells the pituitary—a small gland below the brain—to release growth hormone.

It depends on that gland still being able to make growth hormone.

Then and now
The questionThe old drugCare today
The nameSermorelin (Geref).Ask for the exact ingredient and the pharmacy’s name.
The approvalGeref’s approvals ended in June 2009.As of September 2026, the US market has no approved sermorelin product.
The useThe old approvals covered a hormone test and growth failure in children with a hormone shortage.Sermorelin was never approved for adult treatment.
A past approval does not turn a product prepared today into the old drug.

Was it withdrawn because it was dangerous?

The Food and Drug Administration (FDA) oversees medicines in the US.

In March 2013, the FDA determined that Geref’s withdrawal from sale was not caused by safety or effectiveness problems.

That finding was about the old product’s withdrawal; it did not endorse products offered today.

Ask what medicine would be prescribed today and why it is being considered for your problem.

Can a pharmacy prepare it?

As of September 2026, a pharmacy with a state licence may be able to prepare sermorelin acetate for a patient identified on a valid prescription.

Acetate identifies the exact form of sermorelin used in the old approved drug.

That past use of the ingredient is the basis for this reading of the pharmacy rules.

The pharmacy must also meet the rules for that ingredient and any extra limits in state pharmacy law.

As of September 2026, those rules require an ingredient from a maker registered with FDA, with a document reporting tests of the ingredient.

Any official quality standards for the ingredient must be met, and rules limit regular copying of drugs still sold as ready-made products.

Following these rules when making a medicine still leaves the finished product without FDA approval.

The FDA documents behind this explanation do not specifically say that an ordinary pharmacy may make sermorelin.

This is what those documents appear to mean, not a decision from FDA about making this medicine.

Ask the pharmacist to confirm the ingredient’s full name and explain how your prescription and medicine meet these rules, including any extra rules in your state.

Keep goingWhat an online visit involvesLook for an evaluation before a treatment decision.